1887

Microbial Genomics logo

Volume 10, Issue 1

Strain features of pneumococcal isolates in the pre- and post-PCV10 era in Pakistan Open Access

Abstract

Pakistan is amongst the four countries with the highest number of pneumococcal deaths. While the PCV10 vaccine was introduced in Pakistan in October 2012, data regarding the impact of the vaccine on the population dynamics of in Pakistan remain obscure. Using whole genome sequencing of 190 isolates (nasopharyngeal carriage=75, disease=113, unknown sites=2) collected between 2002 and 2020, this study presents characteristics of pneumococcal strains in Pakistan in the pre- and post-vaccine era. The isolates were characterized on the basis of serotype distribution, genetic lineages (or Global Pneumococcal Sequence Cluster, GPSC) and antibiotic resistance. A high level of diversity in serotype and genetic lineages of pneumococci was observed in Pakistan. Among 190 isolates, we identified 54 serotypes, 67 GPSCs and 116 sequence types (STs) including 23 new STs. The most prevalent GPSCs and their associated serotypes in nasopharyngeal carriage were GPSC54 (expressing serotype 9V), GPSC5 (15A and 7B, and serogroup 24), GPSC25 (15B/15C), GPSC67 (18C) and GPSC376 (6A and 6D). Similarly, among 113 disease-causing isolates, the most prevalent GPSC/serotype combinations were GPSC2 (serotype 1), GPSC10 (serotypes 14, 10A, 19A and 19F), GPSC43 (serotypes 13, 11A, 23B, 35A and 9V), GPSC67 (serotypes 18A and 18C) and GPSC642 (serotype 11A). Of the 190 isolates, the highest levels of resistance were observed against penicillin (58.9 %, =122), erythromycin (29.5 %, =56), clindamycin (13.2 %, =25), co-trimoxazole (94.2 %, =179) and tetracycline/doxycycline (53.2 %, =101). A higher proportion of disease-causing isolates were multidrug resistant as compared to carriage isolates (54 % vs 25 %). Our data suggest limited coverage of PCV10 in nasopharyngeal (21.6 %, 16/74) as well as disease-causing (38.1 %, 16/42) isolates among children ≤5 years old; however, higher valent vaccine PCV13 would increase the coverage rates to 33.8 % in nasopharyngeal and 54.8 % in disease-causing isolates, whereas PCV24/25 would offer the highest coverage rates. Owing to the diversity of serotypes observed during the post-vaccine period, the suggested inclusion of serotype in future vaccine formulations will require investigations with larger data sets with an extended temporal window. This article contains data hosted by Microreact.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial resistance , pneumococcal conjugate vaccine and pneumococcal genomics
Funding
This study was supported by the:
  • Faculty Initiative Fund Lahore University of Management Sciences (Award FIF502)
    • Principle Award Recipient: ShaperMirza
  • Wellcome (Award 206194)
    • Principle Award Recipient: StephenD Bentley
  • Wellcome (Award 09805)
    • Principle Award Recipient: StephenD Bentley
  • Bill and Melinda Gates Foundation (Award OPP1034556)
    • Principle Award Recipient: StephenD Bentley
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001163
2024-01-25
2024-04-29
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/1/mgen001163.html?itemId=/content/journal/mgen/10.1099/mgen.0.001163&mimeType=html&fmt=ahah

References

  1. Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 2013; 3:a010215 [View Article] [PubMed]
     [Google Scholar]
  2. Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health 2018; 6:e744–e757 [View Article] [PubMed]
     [Google Scholar]
  3. Riaz A, Mohiuddin S, Husain S, Yousafzai MT, Sajid M et al. Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan. Int J Infect Dis 2019; 80:28–33 [View Article] [PubMed]
     [Google Scholar]
  4. Pneumococcal vaccination coverage. n.d https://immunizationdata.who.int/pages/coverage/PCV.html?CODE=PAK&ANTIGEN=PCV3&YEAR= accessed 24 August 2022
  5. Mastro TD, Spika JS, Facklam RR, Thornsberry C, Ghafoor A. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. The Lancet 1991; 337:156–159 [View Article]
     [Google Scholar]
  6. Nisar MI, Ahmed S, Jehan F, Shahid S, Shakoor S et al. Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan. Vaccine 2021; 39:1319–1327 [View Article]
     [Google Scholar]
  7. Nisar MI, Nayani K, Akhund T, Riaz A, Irfan O et al. Nasopharyngeal carriage of Streptococcus pneumoniae in children under 5 years of age before introduction of pneumococcal vaccine (PCV10) in urban and rural districts in Pakistan. BMC Infect Dis 2019; 19:114 [View Article] [PubMed]
     [Google Scholar]
  8. Khan F, Khan MA, Ahmed N, Khan MI, Bashir H et al. Molecular characterization of pneumococcal surface protein A (PspA), Serotype Distribution and Antibiotic susceptibility of Streptococcus pneumoniae strains isolated from Pakistan. Infect Dis Ther 2018; 7:277–289 [View Article] [PubMed]
     [Google Scholar]
  9. Shakoor S, Kabir F, Khowaja AR, Qureshi SM, Jehan F et al. Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005-2013. PLoS One 2014; 9:e98796 [View Article] [PubMed]
     [Google Scholar]
  10. Bibi S, Siddiqui TR, Hassan SF, Ahmed W. Report - Colonization rates and immune status of children against Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccine. Pak J Pharm Sci 2017; 30:1791–1796 [PubMed]
     [Google Scholar]
  11. Gladstone RA, Lo SW, Lees JA, Croucher NJ, van Tonder AJ et al. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 2019; 43:338–346 [View Article] [PubMed]
     [Google Scholar]
  12. Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 2019; 19:759–769 [View Article] [PubMed]
     [Google Scholar]
  13. Final Results (Census-2017) | Pakistan Bureau of Statistics. n.d https://www.pbs.gov.pk/content/final-results-census-2017 accessed 24 August 2022
  14. CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application; 2018 www.clsi.org accessed 3 November 2021
  15. Epping L, van Tonder AJ, Gladstone RA, Bentley SD et al. SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data. Microb Genom 2018; 4:e000186 [View Article] [PubMed]
     [Google Scholar]
  16. J. Page A, Taylor B, A. Keane J. Multilocus sequence typing by blast from de novo assemblies against PubMLST. JOSS 2016; 1:118 [View Article]
     [Google Scholar]
  17. Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE Jr et al. Penicillin-binding protein transpeptidase signatures for tracking and predicting β-lactam resistance levels in Streptococcus pneumoniae. mBio 2016; 7:e00756-16 [View Article] [PubMed]
     [Google Scholar]
  18. Metcalf BJ, Chochua S, Gertz RE Jr, Li Z, Walker H et al. Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect 2016; 22:1002 [View Article] [PubMed]
     [Google Scholar]
  19. Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE et al. Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences. BMC Genomics 2017; 18:621 [View Article] [PubMed]
     [Google Scholar]
  20. Lees JA, Harris SR, Tonkin-Hill G, Gladstone RA, Lo SW et al. Fast and flexible bacterial genomic epidemiology with PopPUNK. Genome Res 2019; 29:304–316 [View Article]
     [Google Scholar]
  21. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 2009; 26:1641–1650 [View Article] [PubMed]
     [Google Scholar]
  22. Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom 2016; 2:e000093 [View Article] [PubMed]
     [Google Scholar]
  23. Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA et al. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Microb Genom 2021; 7:000645 [View Article] [PubMed]
     [Google Scholar]
  24. Li H, Durbin R. Fast and accurate short read alignment with burrows-Wheeler transform. Bioinformatics 2009; 25:1754–1760 [View Article] [PubMed]
     [Google Scholar]
  25. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
     [Google Scholar]
  26. van Selm S, van Cann LM, Kolkman MAB, van der Zeijst BAM, van Putten JPM. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun 2003; 71:6192–6198 [View Article] [PubMed]
     [Google Scholar]
  27. Khan EA. Situation Analysis Report on Antimicrobial Resistance in Pakistan-Findings and Recommendations for Antibiotic Use and Resistance. Internet] The Global Antibiotic Resistance Partnership (GARP), Pakistan. n.d https://wwwcddep org/publications/garp-pakistan-situation-analysis
  28. Hayat K, Rosenthal M, Gillani AH, Chang J, Ji W et al. Perspective of key healthcare professionals on antimicrobial resistance and stewardship programs: a multicenter cross-Sectional study from Pakistan. Front Pharmacol 2019; 10:1520 [View Article] [PubMed]
     [Google Scholar]
  29. Ali H, Zafar F, Alam S, Beg AE, Bushra R et al. Drug utilization and prescribing pattern of antibiotics in a tertiary care setups; trends and practices. Pak J Pharm Sci 2018; 31:691–697 [PubMed]
     [Google Scholar]
  30. Saleem Z, Faller EM, Godman B, Malik MSA, Iftikhar A et al. Antibiotic consumption at community pharmacies: a multicenter repeated prevalence surveillance using WHO methodology. Med Access Point Care 2021; 5:23992026211064714 [View Article] [PubMed]
     [Google Scholar]
  31. National AMR Action Plan for Pakistan Antimicrobial Resistance National Action Plan Pakistan Ministry of National Health Services Regulations & Coordination Government of Pakistan. n.d
  32. Javaid N, Sultana Q, Rasool K, Gandra S, Ahmad F et al. Trends in antimicrobial resistance amongst pathogens isolated from blood and cerebrospinal fluid cultures in Pakistan (2011-2015): a retrospective cross-sectional study. PLoS One 2021; 16:e0250226 [View Article] [PubMed]
     [Google Scholar]
  33. Nisar MI, Shahid S, Jehan F, Ahmed S, Shakoor S et al. Antimicrobial resistance in pneumococcal carriage isolates from children under 2 years of age in Rural Pakistan. Microbiol Spectr 2021; 9: [View Article]
     [Google Scholar]
  34. Corcoran M, Mereckiene J, Cotter S, Murchan S, Lo SW et al. Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures. Vaccine 2021; 39:5064–5073 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001163
Loading
Strain features of pneumococcal isolates in the pre- and post-PCV10 era in Pakistan
M Gen 10, 001163 (2024); https://doi.org/10.1099/mgen.0.001163
/content/journal/mgen/10.1099/mgen.0.001163
/content/journal/mgen/10.1099/mgen.0.001163
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error